MME and Alzheimer disease: In contrast to this observation, in rats with aluminum-induced AD-like pathological changes, the systemic administration of telmisartan did not lead to changed neprilysin levels, while showing the improvement of memory and a decrease in the cerebral content of Aβ42 [6].